SEC Form 4 · accession 0001140361-15-009642
Bionik Laboratories Corp. · BNKL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Austin Kibler
Officer — Senior Vice President · Director
Period of report
Feb 26, 2015
Accepted (ET)
Mar 2, 2015 · 4:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001508381
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001F1 | Feb 26, 2015 | D | 90,207,241 | — | D | 50,000 | I | Through AAK Ventures LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Such shares were returned to the Issuer and cancelled as a result of and pursuant to the terms of the acquisition by Issuer of all of the common shares of Bionik Laboratories Inc., a Canadian corporation ("Bionik Canada"), and the issuance by Bionik Canada of 50,000,000 Exchangeable Shares to the former holders of common shares that are exchangeable into 50,000,000 shares of the common stock of the Issuer, which was effective as of February 26, 2015.